Skip to content

Mundipharma Integrity Line

We take compliance very seriously and adhere to the laws and regulations of the countries in which we operate. If you think something is not right, please speak up so that we can address your concerns and take appropriate action.

Please use the Mundipharma Integrity Line to raise your questions or concerns.

© 2024 NAPP PHARMACEUTICALS LIMITED. DOP February 2024 UK-CORP-2200003 v7.1

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”